Vital Signs - The Analyst's Perspective - April 2015 Issue

USD 450.00

* Required Fields

USD 450.00


Be the first to review this product

This issue of Vital Signs, released on May 12, 2015, discusses Roche's acquisition of CAPP Diagnostics, IBM's announcments of deals with Apple, Johnson & Johnson, and Medtronic, 2014 US prescription drug spending trends, and DuPont's acquisition of Taxon Biosciences.

Table of Contents

Vital Signs - The Analyst's Perspective - April 2015 IssueVital Signs - April 2015 IssuesThis week's issue

Related Research

Release Date : 24-Apr-18

Region : North America

Release Date : 20-Nov-17

Region : North America

Release Date : 27-Sep-17

Region : Africa

Release Date : 02-Mar-17

Region : Global

Release Date : 16-Aug-16

Region : North America

Release Date : 31-May-2016

Region : Asia Pacific

Release Date : 27-May-2016

Region : Africa

Release Date : 24-May-2016

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.